EXCLUSIVE: UCL researchers argue that loss of brain volume may in fact be a sign that the treatments are working.

Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...

A decade ago, researchers introduced a new model for studying Alzheimer's disease. Known as "Alzheimer's in a dish," the ...

A new study indicates that the loss of brain volume associated with the Alzheimer's drug lecanemab shows the drug is working ...

Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques rather than neuronal damage.

As a result, the researchers believe that the removal of amyloid plaques, which are abundant in Alzheimer's patients, could account for the observed brain volume changes. And, as such, the volume loss ...

Our condolences to vinos and neckbeards, but drinking alcohol, whether it's red wine, beer or bathtub moonshine, is a no-no ...

Researchers have found that long-term use of drugs for hypertension and high cholesterol also lowers the risk of developing ...

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led ...

A new study finds that brain shrinkage in Alzheimer’s disease varies greatly among individuals, with distinct patterns rather than a uniform progression. These findings may pave the way for ...

A recent study in Nature Neuroscience provides new insights into how amyloid-beta and tau proteins, which accumulate in the ...